These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1302840)

  • 21. Effect of Hyperprolactinemia on Bone Metabolism: Focusing on Osteopenia/Osteoporosis.
    Yun SJ; Sang H; Park SY; Chin SO
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoporosis in men with hyperprolactinemic hypogonadism.
    Greenspan SL; Neer RM; Ridgway EC; Klibanski A
    Ann Intern Med; 1986 Jun; 104(6):777-82. PubMed ID: 3706929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoestrogenism in young women and its influence on bone mass density.
    Meczekalski B; Podfigurna-Stopa A; Genazzani AR
    Gynecol Endocrinol; 2010 Sep; 26(9):652-7. PubMed ID: 20504098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase in bone mass after treatment of hyperprolactinemic amenorrhea.
    Klibanski A; Greenspan SL
    N Engl J Med; 1986 Aug; 315(9):542-6. PubMed ID: 3736637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hyperprolactinaemia and bone mineral density].
    Kostrzak A; Męczekalski B
    Pol Merkur Lekarski; 2015 Aug; 39(230):122-5. PubMed ID: 26319389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of hyperprolactinemia on biohumoral parameters of bone metabolism in women of reproductive age on chronic hemodialysis].
    Petrović MS; Prelević GM; Balint-Perić LjA; Radmilović AV
    Srp Arh Celok Lek; 1992; 120(1-2):15-8. PubMed ID: 1641694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status.
    Stiegler C; Leb G; Kleinert R; Warnkross H; Ramschak-Schwarzer S; Lipp R; Clarici G; Krejs GJ; Dobnig H
    J Bone Miner Res; 1995 May; 10(5):751-9. PubMed ID: 7639111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High bone turnover but normal bone mineral density in women suffering from schizophrenia.
    Bergemann N; Parzer P; Mundt C; Auler B
    Psychol Med; 2008 Aug; 38(8):1195-201. PubMed ID: 18366816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea.
    Biller BM; Baum HB; Rosenthal DI; Saxe VC; Charpie PM; Klibanski A
    J Clin Endocrinol Metab; 1992 Sep; 75(3):692-7. PubMed ID: 1517356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa.
    Audí L; Vargas DM; Gussinyé M; Yeste D; Martí G; Carrascosa A
    Pediatr Res; 2002 Apr; 51(4):497-504. PubMed ID: 11919336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Osteocalcin--a marker of bone metabolism and calcium regulating hormones in steroid osteoporosis].
    Rozhinskaia LIa; Kolesnikova GS; Marova EI; Konnova EV
    Probl Endokrinol (Mosk); 1991; 37(2):26-9. PubMed ID: 1857696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone mineral density following treatment of hyperprolactinemia.
    Park KH; Lee BS; Lee CH; Park TK; Lim SK; Lee HC; Huh KB
    Yonsei Med J; 1988; 29(3):239-43. PubMed ID: 3195155
    [No Abstract]   [Full Text] [Related]  

  • 34. Vertebral body bone mineral content in hyperprolactinemic women.
    Koppelman MC; Kurtz DW; Morrish KA; Bou E; Susser JK; Shapiro JR; Loriaux DL
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1050-3. PubMed ID: 6490793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
    Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone mineral metabolism and its relationship to leptin levels in survivors of childhood leukemia and lymphoma.
    Yaris N; Sözen E; Erduran E; Okten A; Orem A; Cakirbay H
    Pediatr Hematol Oncol; 2005 Sep; 22(6):489-98. PubMed ID: 16169815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disorders of calcium metabolism at various times after renal transplantation.
    Babarykin D; Adamsone I; Amerika D; Folkmane I; Rozental R
    Ann Transplant; 1999; 4(1):46-53. PubMed ID: 10850601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas.
    Andereggen L; Frey J; Andres RH; Luedi MM; Widmer HR; Beck J; Mariani L; Christ E
    Sci Rep; 2021 Mar; 11(1):5122. PubMed ID: 33664388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical markers of bone turnover and bone mineral density in patients with beta-thalassaemia major.
    Eren E; Yilmaz N
    Int J Clin Pract; 2005 Jan; 59(1):46-51. PubMed ID: 15707464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.